Performance and Safety of Mepilex® Up in Leg and Foot Ulcers and Skin Tears
Condition(s) studied
Investigational drug(s) / intervention(s)
Mepilex® Up: Mepilex® Up is a soft silicone foam dressing intended for the management of exuding wounds. The dressing is used as the primary absorbent dressing throughout the investigation according to its instructions for use and local standard clinical practice.
Study summary
This post-market clinical follow-up investigation is designed to evaluate the performance and safety of Mepilex® Up when used for the management of exuding ulcers and skin tears on the leg and foot. Approximately 70 adult participants will be treated with Mepilex® Up and followed for up to 6 weeks to assess wound progression and safety.
Eligibility
Primary outcome measure(s)
- Wound progress towards healing — Up to 6 weeks
Assessment of wound progress compared with the previous visit and classified as Deteriorated, no change, improved, or healed.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Forsåker Vårdcentral | Mölndal | Västra Götaland County |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07782008 on ClinicalTrials.gov ↗ ← All trials in Sweden